28060747|t|25-Hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis.
28060747|a|This study aimed to evaluate the levels of three major hydroxycholesterols (24-, 25-, and 27-hydroxycholesterols) in the serum and cerebrospinal fluid (CSF) of patients with amyotrophic lateral sclerosis (ALS), as well as to show their role in the pathogenesis of ALS experimental models. The level of 25-hydroxycholesterol were higher in untreated ALS patients (n = 30) than in controls without ALS (n = 33) and ALS patients treated with riluzole (n = 9) both in their serum and CSF. The level of 25-hydroxycholesterol in the serum of ALS patients were significantly associated with their disease severity and rate of progression. In the motor neuron-like cell line (NSC34) with the human mutant G93A superoxide dismutase 1 gene (mSOD1-G93A), 25-hydroxycholesterol induced motor neuronal death/ apoptosis via glycogen synthase kinase-3beta and liver X receptor pathways; riluzole treatment attenuated these effects. The expressions of enzymes that synthesize 25-hydroxycholesterol were significantly increased in the brains of early symptomatic mSOD1G93A mice. Our data, obtained from patients with ALS, a cellular model of ALS, and an animal model of ALS, suggests that 25-hydroxycholesterol could be actively involved in the pathogenesis of ALS, mostly in the early symptomatic disease stage, by mediating neuronal apoptosis.
28060747	0	21	25-Hydroxycholesterol	Chemical	MESH:C007997
28060747	57	86	amyotrophic lateral sclerosis	Disease	MESH:D000690
28060747	143	162	hydroxycholesterols	Chemical	MESH:D006888
28060747	164	200	24-, 25-, and 27-hydroxycholesterols	Chemical	-
28060747	248	256	patients	Species	9606
28060747	262	291	amyotrophic lateral sclerosis	Disease	MESH:D000690
28060747	293	296	ALS	Disease	MESH:D000690
28060747	352	355	ALS	Disease	MESH:D000690
28060747	390	411	25-hydroxycholesterol	Chemical	MESH:C007997
28060747	437	440	ALS	Disease	MESH:D000690
28060747	441	449	patients	Species	9606
28060747	484	487	ALS	Disease	MESH:D000690
28060747	501	504	ALS	Disease	MESH:D000690
28060747	505	513	patients	Species	9606
28060747	527	535	riluzole	Chemical	MESH:D019782
28060747	586	607	25-hydroxycholesterol	Chemical	MESH:C007997
28060747	624	627	ALS	Disease	MESH:D000690
28060747	628	636	patients	Species	9606
28060747	756	761	NSC34	CellLine	CVCL:D356
28060747	772	777	human	Species	9606
28060747	785	812	G93A superoxide dismutase 1	CellLine	CVCL:B0K0
28060747	825	829	G93A	DNAMutation	tmVar:c|SUB|G|93|A;HGVS:c.93G>A;VariantGroup:0;CorrespondingGene:2932;CorrespondingSpecies:9606
28060747	832	853	25-hydroxycholesterol	Chemical	MESH:C007997
28060747	877	882	death	Disease	MESH:D003643
28060747	898	928	glycogen synthase kinase-3beta	Gene	2932
28060747	960	968	riluzole	Chemical	MESH:D019782
28060747	1048	1069	25-hydroxycholesterol	Chemical	MESH:C007997
28060747	1144	1148	mice	Species	10090
28060747	1174	1182	patients	Species	9606
28060747	1188	1191	ALS	Disease	MESH:D000690
28060747	1213	1216	ALS	Disease	MESH:D000690
28060747	1241	1244	ALS	Disease	MESH:D000690
28060747	1260	1281	25-hydroxycholesterol	Chemical	MESH:C007997
28060747	1332	1335	ALS	Disease	MESH:D000690
28060747	Positive_Correlation	MESH:C007997	MESH:D003643
28060747	Positive_Correlation	MESH:C007997	MESH:D000690
28060747	Association	MESH:C007997	2932
28060747	Negative_Correlation	MESH:D019782	MESH:D000690
28060747	Negative_Correlation	MESH:C007997	MESH:D019782

